Centaurothamnus maximus
Centaurothamnus maximus · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Centaurothamnus maximus is a unique botanical species that has garnered scientific interest due to its diverse chemical profile. Research focusing on the aerial parts of this plant has identified several key bioactive compounds, including Chlorohyssopifolin B, Chlorojanerin, Cynaropikrin, and Hydroxyjanerin. When extracted from the leaf, these chemical constituents demonstrate significant biological potential. Specifically, studies have investigated the antimicrobial activities of these preparations against various pathogens. Recent findings highlight its effectiveness in inhibiting the growth of E. coli, suggesting therapeutic possibilities for the plant.
- Synonyms
- Centaurea Verbascifolia · Centaurea Maxima
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Centaurothamnus maximus is a unique botanical species that is frequently associated with different taxonomic designations. Within scientific literature, this plant is recognized by the synonym Centaurea maxima. It is also formally linked to the name Centaurea verbascifolia in various botanical records. These overlapping names highlight the complex historical classification of the species. Understanding these relationships is essential for researchers studying its true evolutionary lineage.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Centaurothamnus maximus is a unique organism belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further falls into the order Asterales, which highlights its evolutionary placement. The plant is a member of the family Asteraceae, sharing traits with many well-known flowering species. Finally, its distinct characteristics place it within its own specialized genus, Centaurothamnus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Centaurothamnus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Centaurothamnus maximus is a unique species with a highly specific geographical presence. Its distribution is primarily concentrated within the Asia-Temperate region. Specifically, this plant can be found across the rugged landscapes of the Arabian Peninsula. It thrives in certain areas of Saudi Arabia, making it a notable part of the local flora. Furthermore, the species extends its reach into the territory of Yemen, completing its regional footprint.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Centaurothamnus maximus is characterized by its unique growth form as an herb.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Centaurothamnus maximus has demonstrated significant antimicrobial potential through the isolation of bioactive compounds from its leaves. Researchers identified a new oxygenated homoditerpenoid, specifically CM-1, which exhibits activity against several key microorganisms. Testing via the agar well diffusion method revealed that the ethanol extract of the plant is effective against a broad range of microbes, including B. subtilis, S. aureus, and M. smegmatis. The newly characterized compound CM-1 specifically showed potency at a minimum inhibitory concentration of 20 μg/ml against these bacteria. These findings suggest that this endemic plant could serve as a vital lead for developing new agents to combat multidrug-resistant infections.
Compounds
Centaurothamnus maximus is a leafy shrub belonging to the Asteraceae family that is indigenous to the southwestern Arabian Peninsula. Recent phytochemical investigations have successfully isolated several specific compounds from the aerial parts of this plant. Among these identified constituents are the sesquiterpene lactones chlorohyssopifolin B, cynaropikrin, chlorojanerin, and hydroxyjanerin. Additionally, the flavonoid isorhamnetin was also found to be present within the species. These findings contribute to a better understanding of the chemical characterization and chemotaxonomic significance of this unique plant.
Conditions
Centaurothamnus maximus demonstrates significant antimicrobial potential through its ethanol extract against several bacterial species. This plant effectively treats B. subtilis, S. aureus, and M. smegmatis, with a specific isolated compound showing high activity against these microbes. Additionally, the ethanol extract of the plant is capable of treating E. coli. It also shows effectiveness in treating P. aeruginosa. These findings highlight the plant's diverse ability to combat various bacterial pathogens.
Preparations
Centaurothamnus maximus is prepared as aerial parts for the purpose of phytochemical characterization. Researchers utilized these specific plant components to isolate several important guaianolide sesquiterpene lactones. Through the study of these aerial parts, two previously unidentified compounds were successfully discovered. The chemical analysis of this plant material also allowed for the isolation of seven other known compounds. This targeted use of the aerial parts provided the necessary material to propose a biosynthetic pathway for the identified molecules.
Parts used
Centaurothamnus maximus is an endemic plant species that contains specialized leaf structures containing bioactive compounds. Researchers have focused on isolating unique oxygenated homoditerpenoids specifically from these leaves to explore their medicinal properties. Through the use of ethanol extracts, scientists identified a new compound, CM-1, which demonstrates significant antimicrobial potential. This specific leaf-derived substance showed effectiveness against various bacteria, including B. subtilis and S. aureus. Ultimately, studying the chemical composition of these leaves may provide a vital foundation for developing new agents to combat multidrug-resistant infections.